Showing results (71-80 of 6,496) with videos related to
Sort By:
Pageof 650
Human Vaccines & Immunotherapeutics|March 25, 2021
Digital tools, multidisciplinarity and innovation for communicating vaccine safety in the COVID-19 eraFrancesco Gesualdo, Lucie M Bucci, Caterina Rizzo, et al.Human Vaccines & Immunotherapeutics|March 4, 2021
Influenza and Measles-MMR: two case study of the trend and impact of vaccine-related Twitter posts in Spanish during 2015-2018Lucia Prieto Santamaría, Juan Manuel Tuñas, Diego Fernández Peces-Barba, et al.Human Vaccines & Immunotherapeutics|March 5, 2021
Current status of antigen-specific T-cell immunotherapy for advanced renal-cell carcinomaYuexin Xu, Chris P Miller, Edus H Warren, et al.Human Vaccines & Immunotherapeutics|March 10, 2021
Neoantigen-reactive T cells exhibit effective anti-tumor activity against colorectal cancerYaojun Yu, Jing Zhang, Leyi Ni, et al.Human Vaccines & Immunotherapeutics|July 26, 2019
Uptake of 13-Valent Pneumococcal Conjugate Vaccine among US Adults Aged 19 to 64 Years with Immunocompromising ConditionsJeffrey Vietri, James Harnett, Birol Emir, et al.Human Vaccines & Immunotherapeutics|July 27, 2019
Immunogenicity and safety of a meningococcal serogroups A and C tetanus toxoid conjugate vaccine (MenAC-TT): two immune schedules in toddles aged 12-23 months in ChinaJialei Hu, Hongguang Li, Kai Chu, et al.Human Vaccines & Immunotherapeutics|July 25, 2019
Embedding the delivery of antenatal vaccination within routine antenatal care: a key opportunity to improve uptakeChristopher R Wilcox, Charlotte Woodward, Rebecca Rowe, et al.Human Vaccines & Immunotherapeutics|October 29, 2013
Japanese encephalitis: the virus and vaccinesSang-Im Yun, Young-Min LeeHuman Vaccines & Immunotherapeutics|October 29, 2013
Safety of an Escherichia coli-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine: an open-label phase I clinical trialYue-Mei Hu, Shou-Jie Huang, Kai Chu, et al.Human Vaccines & Immunotherapeutics|November 20, 2013
Epidemiology of vaccine hesitancy in the United StatesMariam Siddiqui, Daniel A Salmon, Saad B OmerPageof 650